Erik Tambuyzer

668 total citations
12 papers, 431 citations indexed

About

Erik Tambuyzer is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Erik Tambuyzer has authored 12 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Economics and Econometrics. Recurrent topics in Erik Tambuyzer's work include Genomics and Rare Diseases (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Biotechnology and Related Fields (5 papers). Erik Tambuyzer is often cited by papers focused on Genomics and Rare Diseases (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Biotechnology and Related Fields (5 papers). Erik Tambuyzer collaborates with scholars based in Belgium, United States and Netherlands. Erik Tambuyzer's co-authors include Stephen C. Groft, Kristina Larsson, Robert A. Preti, Marco Prunotto, Benjamin Vandendriessche, Philip J. Brooks, Christopher P. Austin, Kay E. Davies, Tudor I. Oprea and Katherine I. Miller Needleman and has published in prestigious journals such as Nature Biotechnology, Nature Reviews Drug Discovery and Acta Paediatrica.

In The Last Decade

Erik Tambuyzer

11 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Tambuyzer Belgium	5	151	145	112	59	47	12	431
Anneliene Hechtelt Jonker France	13	184 1.2×	256 1.8×	83 0.7×	45 0.8×	41 0.9×	28	515
James Valentine United States	4	129 0.9×	96 0.7×	74 0.7×	27 0.5×	42 0.9×	7	315
Tan T. Nguyen United States	6	67 0.4×	116 0.8×	63 0.6×	29 0.5×	28 0.6×	7	320
Katherine I. Miller Needleman United States	5	119 0.8×	88 0.6×	54 0.5×	21 0.4×	37 0.8×	8	260
Stéphanie Nguengang Wakap France	4	275 1.8×	494 3.4×	101 0.9×	71 1.2×	70 1.5×	7	854
Malorye Allison United States	12	205 1.4×	67 0.5×	48 0.4×	20 0.3×	85 1.8×	37	584
Tamás Zelei Hungary	10	56 0.4×	47 0.3×	130 1.2×	46 0.8×	14 0.3×	26	336
Ingrid Slade United Kingdom	9	132 0.9×	238 1.6×	26 0.2×	51 0.9×	19 0.4×	10	431
Patrick F. Terry United States	10	140 0.9×	339 2.3×	70 0.6×	17 0.3×	11 0.2×	14	547
Subhashini Chandrasekharan United States	16	382 2.5×	150 1.0×	54 0.5×	130 2.2×	7 0.1×	29	788

Countries citing papers authored by Erik Tambuyzer

Since Specialization

Citations

This map shows the geographic impact of Erik Tambuyzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Tambuyzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Tambuyzer more than expected).

Fields of papers citing papers by Erik Tambuyzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Tambuyzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Tambuyzer. The network helps show where Erik Tambuyzer may publish in the future.

Co-authorship network of co-authors of Erik Tambuyzer

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Tambuyzer. A scholar is included among the top collaborators of Erik Tambuyzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Tambuyzer. Erik Tambuyzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tambuyzer, Erik, Benjamin Vandendriessche, Christopher P. Austin, et al.. (2020). Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery. 19(4). 291–291. 3 indexed citations

Tambuyzer, Erik, Benjamin Vandendriessche, Christopher P. Austin, et al.. (2019). Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery. 19(2). 93–111. 222 indexed citations

Tambuyzer, Erik, et al.. (2014). The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development. Orphanet Journal of Rare Diseases. 9(Suppl 1). O18–O18. 1 indexed citations

Taruscio, Domenica, Luis A. Barrera, Timothy R. Coté, et al.. (2012). The need for worldwide policy and action plans for rare diseases. Acta Paediatrica. 101(8). 805–807. 65 indexed citations

Dyck, Walter Van, et al.. (2012). Acute coronary syndrome: What is the cost-effectiveness of prevention, point-of-care technology and telemonitoring?. Health Policy and Technology. 1(3). 173–177. 5 indexed citations

Dyck, Walter Van, et al.. (2012). Unlocking the value of personalised healthcare in Europe—breast cancer stratification. Health Policy and Technology. 1(2). 63–68. 8 indexed citations

Tambuyzer, Erik. (2010). Rare diseases, orphan drugs and their regulation: questions and misconceptions. Nature Reviews Drug Discovery. 9(12). 921–929. 117 indexed citations

Tambuyzer, Erik. (2010). Towards A Framework for Personalized Healthcare: Lessons Learned from the Field of Rare Diseases. Personalized Medicine. 7(5). 569–586. 4 indexed citations

Tambuyzer, Erik. (2009). Impact of rare disease public policies on patients and physicians. Clinical Therapeutics. 31. S196–S197. 1 indexed citations

10.

Brown, Phil, et al.. (2001). Human cell- and tissue- based products: Progress, promise and regulatory issues. Journal of Commercial Biotechnology. 7(4). 2 indexed citations

11.

Tambuyzer, Erik, et al.. (2001). Orphan medicinal products: A challenge from an industry point of view?. Pharmaceuticals Policy and Law. 3(1). 47–54. 1 indexed citations

12.

Fears, Robin & Erik Tambuyzer. (1999). Core ethical values for European bioindustries. Nature Biotechnology. 17(2). 114–115. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact